Long-Term Outlook and Developmental Monitoring

The journey with EMAtS (Doose Syndrome) is often described as a marathon rather than a sprint. While the early “stormy phase” is intense and frightening, the long-term outlook for many children is optimistic, though it remains a highly variable condition. Understanding the observational statistics and the typical path toward remission can help you plan for your child’s future.

Seizure Freedom: The Statistical Picture

Long-term studies of children with EMAtS show that a significant portion eventually achieve control of their seizures, though these statistics come from varied historical cohorts and should not be used to predict an individual child’s exact future.

• Success Rates: Approximately 57% to 62% of children with EMAtS eventually became seizure-free in long-term cohorts ^[1][2].
• The Timeline: Remission is rarely immediate. In one cohort, it took an average of 5.1 years from the start of the first seizure to achieve permanent seizure freedom ^[1].
• Drug Resistance: Roughly 38% of children may continue to have seizures that are difficult to control with current medications ^[1]. Factors that may make seizure freedom less likely include persistent developmental delays during the course of the illness and specific EEG patterns that resemble other syndromes like Lennox-Gastaut ^[2][3].

Developmental and Cognitive Monitoring

Because EMAtS is a developmental and epileptic encephalopathy, the condition can impact how a child learns and grows. However, outcomes vary significantly across different studies and eras:

• Cognitive Outcomes: In one large study, 47% of children had normal cognitive development, while a different historical cohort tracking different parameters reported intellectual disability in about 58% ^[2][1].
• Predicting Progress: A key factor in long-term cognitive health is your child’s development before the seizures began. Children who met all milestones on time before their first seizure generally have a more favorable prognosis than those who had early delays ^[1][2].
• Executive Function and Behavior: Even if a child’s overall intelligence is in the normal range, they may still face challenges with executive function (planning and focus), attention (ADHD-like symptoms), and social communication ^[4][5].

Ongoing monitoring is essential. Your child should have regular assessments of their language, learning, and behavior to identify any areas where they might need extra support, such as speech therapy or an Individualized Education Program (IEP) at school.

Transitioning Off the Ketogenic Diet

For many families, the ketogenic diet is the “anchor” of their child’s treatment. However, the diet is rarely intended to be lifelong.

• Individualized Tapering: In general pediatric practice, if a child has been completely seizure-free for two years, doctors may begin to discuss a gradual taper off the diet ^[6][7]. While this is a common benchmark, decisions are highly individualized based on seizure history, EEG findings, genotype, and family preference.
• The Tapering Process: You should never alter the diet’s strict ratios or stop the diet “cold turkey” on your own. A taper is supervised by the epilepsy diet team and involves slowly changing the diet over several months, often while monitoring the brain’s activity with an EEG ^[6].
• Relapse Risk: While most children who achieve long-term seizure freedom stay that way, a small number may experience a return of seizures—ranging from mild staring spells to major seizures—during or after the taper. In many cases, these can be evaluated and managed with a small dose of medication or by returning to a less restrictive version of the diet ^[8][7].

Looking Ahead

While you may still be in the thick of the “stormy phase,” it is important to remember that a “stormy” start does not necessarily mean a poor long-term outcome ^[1]. With early intervention—particularly the early consideration of dietary therapy—and close developmental monitoring, many children with EMAtS grow up to experience significant improvements in seizure control. Your role as an advocate is to ensure your care team continues to look at the “whole child,” focusing as much on their learning and development as they do on their seizure counts.